≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Marginal zone B-cell lymphoma, including Hilmo

Endpoint Browser PheWeb

C3_MARGINAL_ZONE_LYMPHOMA_WIDE

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — C83.80, C83.89
  • Cause of death: ICD-10 — C83.80, C83.89
  • Cancer registry: Topography ICD-O-3 — ANY
  • Cancer registry: Morphology ICD-O-3 — 9699
  • Cancer registry: Behaviour codes — 3

3 out of 7 registries used, show all original rules.

576

4. Check minimum number of events

None

576

5. Include endpoints

None

576

6. Filter based on genotype QC (FinnGen only)

557

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze
DF12

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

All Female Male
Number of individuals 557 275 282
Unadjusted period prevalence (%) 0.11 0.10 0.13
Median age at first event (years) 65.64 63.90 67.33

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
576
Matched controls
5760
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JN4BD
NOMESCO Finland
Extensive body CT
31.5
319.9
236
124
C83.80
ICD-10 Finland
B-cell lymphoma in marginal zone
+∞
307.7
447
*
XW000
NOMESCO Finland
Bone marrow biopsy
55.7
307.7
228
67
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
152.2
307.7
297
40
JN6AD
NOMESCO Finland
CT of torso and neck
131.2
211.9
107
10
A03FA01
ATC
metoclopramide; systemic, rectal
11.6
183.6
253
364
H02AB02
ATC
dexamethasone; systemic
43.2
182.4
112
32
JN4AD
NOMESCO Finland
Body CT examination
15.5
177.0
178
162
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
1966.6
159.1
147
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
27.0
153.4
110
50
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
27.4
146.4
104
46
A04AA01
ATC
ondansetron; systemic, rectal
23.2
140.6
107
56
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
128.0
118
*
C83.89
ICD-10 Finland
Other types of diffuse non-Hodgkin's lymphoma
+∞
123.5
114
*
WF002
NOMESCO Finland
Radical radiotherapy
280.4
114.3
113
5
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
659.1
113.0
108
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
105.5
98
*
L03AA02
ATC
filgrastim; parenteral
592.4
103.0
99
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
102.2
95
*
L03AA13
ATC
pegfilgrastim; parenteral
391.3
99.3
97
*
XX3DW
NOMESCO Finland
Time consuming IT work
10.9
98.2
117
132
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
549.2
96.4
93
*
WW500
NOMESCO Finland
Blood transfusion
18.7
86.3
71
43
M04AA01
ATC
allopurinol; systemic
5.9
85.4
204
489
WZC00
NOMESCO Finland
Treatment plan or consultation
5.1
84.1
297
989
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
313.5
81.8
81
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
419.4
75.6
74
*
C85.1
ICD-10 Finland
B-cell lymphoma, unspecified
+∞
74.6
70
*
TNE25
NOMESCO Finland
Drill biopsy of bone marrow, pelvis
37.5
71.7
45
13
EP1AE
NOMESCO Finland
Neck ultrasound examination
9.8
71.5
89
105
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
8.5
67.3
95
131
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
716.1
66.3
64
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.5
65.1
153
354
ZX120
NOMESCO Finland
Intravenous
6.7
60.5
108
192
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
91.5
59.3
65
8
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
58.3
55
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.1
52.7
130
310
Z51.5
ICD-10 Finland
Palliative care
8.4
49.9
69
92
PJA10
NOMESCO Finland
Exploration of lymph nodes
85.1
48.9
54
7
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
47.6
45
*
D69.6
ICD-10 Finland
Thrombocytopenia, unspecified
13.9
47.4
45
35
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
133.6
46.5
49
*
R50.9
ICD-10 Finland
Fever, unspecified
4.3
46.2
146
421
WF049
NOMESCO Finland
Radiotherapy of metastasis
249.4
45.7
46
*
C85.7
ICD-10 Finland
Other specified types of non-Hodgkin lymphoma
+∞
45.4
43
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
44.3
42
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
118.9
41.3
44
*
9699/3-C77.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph node, NOS
+∞
41.1
39
*
C83.00
ICD-10 Finland
Lymphocytic lymphoma
+∞
41.1
39
*
C83.8
ICD-10 Finland
Other non-follicular lymphoma
+∞
41.1
39
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
426.0
40.6
40
*
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.1
39.4
46
49
C83.3
ICD-10 Finland
Diffuse large B-cell lymphoma
+∞
39.0
37
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
4.5
38.8
109
285
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
8.6
38.5
51
64
C61
ICD-10 Finland
Malignant neoplasm of prostate
402.9
38.5
38
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
37.9
36
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
37.9
36
*
H02AB06
ATC
prednisolone; systemic
3.1
36.8
362
2049
JMA10
NOMESCO Finland
Transabdominal total splenectomy
104.4
36.2
39
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
35.8
34
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
35.8
34
*
9699/3-C16.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of stomach, NOS
+∞
35.8
34
*
1XC02, ,
NOMESCO Finland
46.4
35.5
43
10
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
50.1
35.2
42
9
WX302
NOMESCO Finland
Thoracal epidural anesthesy
9.0
35.2
45
54
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.0
35.2
56
87
9689/3-C42.2
ICD-O-3
Splenic marginal zone B-cell lymphoma of spleen
+∞
34.7
33
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
127.8
34.1
36
*
JN4CD
NOMESCO Finland
Very extensive body CT
12.4
33.7
34
29
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
33.7
32
*
WX402
NOMESCO Finland
General anaesthesia
3.4
33.0
150
543
C82.9
ICD-10 Finland
Follicular lymphoma, unspecified
+∞
32.6
31
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
42.9
32.6
40
10
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
31.9
189
798
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.8
31.7
344
1995
130
Kela drug reimbursment
Malignant tumour
+∞
31.5
30
*
HA1AA
NOMESCO Finland
X-ray mammography
7.4
31.4
47
68
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.5
31.4
84
210
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
329.9
31.1
31
*
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
7.4
30.5
46
67
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
30.5
29
*
C82.1
ICD-10 Finland
Follicular lymphoma grade II
+∞
30.5
29
*
9680/3-C77.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph node, NOS
+∞
30.5
29
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
112.8
30.0
32
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.5
29.6
61
122
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
67.6
28.2
32
5
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
9.9
28.2
33
35
PJA12
NOMESCO Finland
Sentinel node biopsy
295.1
28.0
28
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
27.3
26
*
H02AB07
ATC
prednisone; oral
3.2
27.1
128
470
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.6
26.6
236
1211
R16.1
ICD-10 Finland
Splenomegaly, not elsewhere classified
141.4
25.8
27
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.8
25.2
60
136
WZC30
NOMESCO Finland
Teaching
3.3
24.5
110
390
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
36.3
24.5
31
9
UGC12
NOMESCO Finland
Flexible bronchoscopy
4.0
23.4
72
199
ZX112
NOMESCO Finland
Subcutaneous
21.2
23.3
34
17
9699/3-C42.1
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of bone marrow
+∞
23.1
22
*
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
67.9
23.0
26
*
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
4.4
22.8
60
147
ZX070
NOMESCO Finland
Intensity modified radiotherapy
239.1
22.8
23
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
125.0
22.7
24
*
D70.89
ICD-10 Finland
Neutropenic splenomegaly
33.8
22.6
29
9
NEA10
NOMESCO Finland
Exploration of soft tissue of pelvis, percutaneous
54.3
22.3
26
5
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
65.2
22.0
25
*
9699/3-C77.8
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
22.0
21
*
A07AA02
ATC
nystatin; oral
4.4
21.9
59
147
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
83.4
21.8
24
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.7
21.6
35
55
N02AA05
ATC
oxycodone; systemic
2.9
21.6
120
479
CFA20
NOMESCO Finland
Biopsy of conjunctiva
45.2
21.6
26
6
J05AB11
ATC
valaciclovir; oral
2.9
21.4
115
450
Z3231
NOMESCO Finland
Registered nurse
2.5
21.2
185
924
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
29.3
21.1
28
10
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
21.0
20
*
9699/3-C34.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of lung, NOS
+∞
21.0
20
*
115
Kela drug reimbursment
Breast cancer
+∞
21.0
20
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
21.0
20
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
217.5
20.7
21
*
J01MA12
ATC
levofloxacin; systemic
2.7
20.5
140
621
A02BC02
ATC
pantoprazole; systemic
2.5
20.1
431
3137
9699/3-C07.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of parotid gland
+∞
19.9
19
*
C88.4
ICD-10 Finland
Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lyphoma]
+∞
19.9
19
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.5
19.7
154
728
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
47.8
19.3
23
5
D64.9
ICD-10 Finland
Anaemia, unspecified
3.0
19.1
95
355
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.6
18.5
123
536
D11.0
ICD-10 Finland
Benign neoplasm: Parotid gland
7.1
18.4
28
41
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
45.6
18.4
22
5
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.2
18.0
77
263
116
Kela drug reimbursment
Prostate cancer
+∞
17.8
17
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
17.8
17
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
17.8
17
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
17.8
17
*
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
185.5
17.6
18
*
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.3
17.5
26
37
B01AB05
ATC
enoxaparin; parenteral
2.2
17.4
205
1150
TGC00
NOMESCO Finland
Bronchial lavation
5.7
17.3
33
61
ZX108
NOMESCO Finland
Inhalation
26.5
17.0
23
9
TPH07
NOMESCO Finland
Cathetrisation of artery
2.9
16.9
87
331
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.4
16.8
64
203
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
4.1
16.8
48
125
A04AD12
ATC
aprepitant; systemic
+∞
16.7
16
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
5.8
16.7
31
56
L01AA02
ATC
chlorambucil; oral
174.9
16.6
17
*
Z2221
NOMESCO Finland
Medical doctor
2.3
16.5
172
913
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
12.2
16.2
29
25
ZXE00
NOMESCO Finland
One hour or less
2.1
16.1
239
1455
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.9
15.7
48
131
9699/3-C69.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of conjunctiva
+∞
15.7
15
*
9699/3-C69.6
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of orbit, NOS
+∞
15.7
15
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
15.7
15
*
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
7.2
15.4
23
33
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
15.3
225
1361
CBA10
NOMESCO Finland
Biopsy of eyelid
25.8
14.8
20
8
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.0
14.7
258
1658
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
5.6
14.6
28
52
B01AB10
ATC
tinzaparin; parenteral
3.1
14.6
65
227
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.1
14.6
180
1016
JMA11
NOMESCO Finland
Laparoscopic total splenectomy
153.7
14.5
15
*
CAA30
NOMESCO Finland
Biopsy of orbit
153.7
14.5
15
*
D73.1
ICD-10 Finland
Hypersplenism
153.7
14.5
15
*
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.7
14.2
33
73
D47.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified
43.7
14.2
17
*
HA1AT
NOMESCO Finland
Biopsy of mammary glands with ultrasound guidance
24.5
13.9
19
8
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.6
13
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
13.6
13
*
C82.01
ICD-10 Finland
Follicular nodular lymphoma, grade I
+∞
13.6
13
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
13.6
13
*
1AA09, ,
NOMESCO Finland
+∞
13.6
13
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
13.6
13
*
C83.01
ICD-10 Finland
Lymphoplasmacytic lymphoma
+∞
13.6
13
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
13.6
13
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
143.2
13.5
14
*
UJF32
NOMESCO Finland
Coloscopy
2.1
13.4
175
1003
R06AE07
ATC
cetirizine; oral
1.9
13.3
243
1569
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
13.2
232
1476
WW200
NOMESCO Finland
Immunization
5.1
12.7
27
55
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
12.5
12
*
B72
ICPC
Hodgkin Lymphoma
+∞
12.5
12
*
C50.21
ICD-10 Finland
Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor
+∞
12.5
12
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
12.5
12
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
12.5
12
*
C82.00
ICD-10 Finland
Follicular nodular non-Hodgkin's lymphoma, ungraded
+∞
12.5
12
*
HAB40
NOMESCO Finland
Wedge excision of mammary gland
24.9
12.5
17
7
D72.8
ICD-10 Finland
Other specified disorders of white blood cells
20.6
12.5
18
9
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
132.8
12.5
13
*
XW4XT
NOMESCO Finland
Biopsy of other inner organ with radiological guidance guidance
132.8
12.5
13
*
WX110
NOMESCO Finland
Infiltration anesthesia
2.0
12.4
393
3015
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
27.4
12.1
16
6
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
4.7
12.0
28
62
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
47.7
11.9
14
*
L02BG04
ATC
letrozole; oral
16.8
11.7
18
11
ED1AA
NOMESCO Finland
Mandibular X-ray examination
23.5
11.6
16
7
C88.0
ICD-10 Finland
Waldenström macroglobulinaemia
+∞
11.5
11
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
11.5
11
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
11.5
11
*
C83.0
ICD-10 Finland
Small cell B-cell lymphoma
+∞
11.5
11
*
9699/3-C44.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of skin, NOS
+∞
11.5
11
*
2008X
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Other named variants
+∞
11.5
11
*
9699/3-C08.0
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of submandibular gland
+∞
11.5
11
*
PJD42
NOMESCO Finland
Excision of axillary lymph nodes
122.4
11.5
12
*
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
35.8
11.3
14
*
J05AB01
ATC
aciclovir; systemic
2.1
11.1
135
748
ZZR00
NOMESCO Finland
Flap of skin
44.2
11.0
13
*
HA4AT
NOMESCO Finland
Labeling mammary gland pathology with ultrasound guidance
44.2
11.0
13
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
10.8
53
195
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
28.6
10.8
14
5
EBA15
NOMESCO Finland
Extraction of multiple teeth
3.8
10.7
33
91
L02AE02
ATC
leuprorelin; implant, parenteral
61.2
10.7
12
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
10.4
10
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
WB401
NOMESCO Finland
Simple antibody therapy of primary tumour
+∞
10.4
10
*
JN5JR
NOMESCO Finland
Extensive PET-CT of upper body metabolism (eyebrows to thighs)
+∞
10.4
10
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
10.4
10
*
L01BC06
ATC
capecitabine; oral
+∞
10.4
10
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
10.4
10
*
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
9.8
10.3
20
21
P01BA02
ATC
hydroxychloroquine; oral
2.6
10.3
62
254
WZC10
NOMESCO Finland
Written specialist consultation based on a referral from a dentist or a physician
3.6
10.3
35
103
ELB30
NOMESCO Finland
Excision of submandibular gland
19.2
10.3
15
8
J01MA14
ATC
moxifloxacin; systemic
2.5
10.1
65
275
212
Kela drug reimbursment
Gout
5.2
10.1
21
42
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
14.9
10.0
16
11
D31.6
ICD-10 Finland
Benign neoplasm: Orbit, unspecified
40.8
10.0
12
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.4
9.7
36
112
QBA25
NOMESCO Finland
Destruction of lesion of skin of trunk
15.4
9.6
15
10
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
9.5
65
284
Z51.0
ICD-10 Finland
Radiotherapy session
101.6
9.4
10
*
YNB00
NOMESCO Finland
Excision of bone marrow for transplantation
101.6
9.4
10
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
30.6
9.4
12
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
9.4
9
*
C81.1
ICD-10 Finland
Nodular sclerosis classical Hodgkin lymphoma
+∞
9.4
9
*
C82.2
ICD-10 Finland
Follicular lymphoma grade III, unspecified
+∞
9.4
9
*
9699/3-C80.9
ICD-O-3
Marginal zone B-cell lymphoma, NOS, of unknown primary site
+∞
9.4
9
*
9591/3-C77.9
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph node, NOS
+∞
9.4
9
*
9591/3-C77.0
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of lymph nodes of head, face and neck
+∞
9.4
9
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
9.4
9
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
9.4
9
*
9689/3-C42.1
ICD-O-3
Splenic marginal zone B-cell lymphoma of bone marrow
+∞
9.4
9
*
Z85.7
ICD-10 Finland
Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues
+∞
9.4
9
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
22.1
9.4
13
6
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.8
9.3
197
1300
N03AX16
ATC
[U] pregabalin
1.9
9.3
145
871
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
9.3
197
1301
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.2
9.3
37
121
A41.9
ICD-10 Finland
Sepsis, unspecified
3.7
9.2
29
81
WZB00
NOMESCO Finland
Telephone prescription or other care instructions
1.8
9.2
164
1027
B01AB04
ATC
dalteparin; parenteral
3.4
9.0
32
97
Z3229
NOMESCO Finland
Other healthcare associate professional
2.5
9.0
59
252
UKC02
NOMESCO Finland
Cystoscopy
2.1
8.8
98
522
Z3226
NOMESCO Finland
Physiotherapist
2.0
8.8
112
626
WX002
NOMESCO Finland
Sedation and analgesia
1.9
8.8
124
718
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
9.7
8.8
17
18
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
3.1
8.7
36
120
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.8
8.7
26
70
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
50.8
8.7
10
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
16.6
8.6
13
8
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.7
8.5
281
2083
ZXE20
NOMESCO Finland
More than three and less than five hours
2.2
8.4
80
401
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
91.3
8.4
9
*
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
91.3
8.4
9
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
91.3
8.4
9
*
C44.21
ICD-10 Finland
Basocellular carcinoma of the skin of the outer ear and the outer ear canal
91.3
8.4
9
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.0
8.4
18
37
N05CF01
ATC
zopiclone; oral
1.7
8.4
194
1305
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.4
8
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
8.4
8
*
A79
ICPC
Malignancy NOS
+∞
8.4
8
*
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
+∞
8.4
8
*
9591/3-C42.1
ICD-O-3
Malignant lymphoma, non-Hodgkin, NOS, of bone marrow
+∞
8.4
8
*
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
8.4
8
*
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
8.4
8
*
D80.8
ICD-10 Finland
Other immunodeficiencies with predominantly antibody defects
+∞
8.4
8
*
L01CB01
ATC
etoposide; systemic
+∞
8.4
8
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
8.4
8
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
8.4
8
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
11.0
8.3
15
14
XKD00
NOMESCO Finland
Uroflowmetry
2.0
8.3
94
505
N02BE01
ATC
paracetamol; systemic, rectal
2.2
8.3
510
4497
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
8.2
143
886
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
8.1
73
358
D37.00
ICD-10 Finland
Aryepiglottic fold marginal zone
17.5
8.1
12
7
D11.70
ICD-10 Finland
Gland sublingual
33.9
8.1
10
*
JFB00
NOMESCO Finland
Partial resection of small intestine
9.1
8.1
16
18
B02.9
ICD-10 Finland
Zoster without complication
2.6
8.1
49
202
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
3.0
8.1
36
126
B25.8
ICD-10 Finland
Other cytomegaloviral diseases
22.4
8.0
11
5
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
7.4
8.0
18
25
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
13.3
7.9
13
10
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
3.4
7.7
27
81
TPJ00
NOMESCO Finland
Biopsy of superficial lymph node
45.6
7.7
9
*
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
45.6
7.7
9
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
7.6
249
1825
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
18.7
7.6
11
6
THW99
NOMESCO Finland
Other minor procedure in surgery of mammary gland
25.4
7.6
10
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
7.3
7.5
17
24
ELB00
NOMESCO Finland
Excision or exploration of lesion of salivary gland
81.1
7.4
8
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
81.1
7.4
8
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
81.1
7.4
8
*
Y77
ICPC
Malignant neoplasm prostate
81.1
7.4
8
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
81.1
7.4
8
*
R4110
NOMESCO Finland
Physiotherapy
1.7
7.4
149
960
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
7.0
7.3
17
25
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.0
7.3
81
430
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
11.1
7.3
13
12
9823/3-C42.1
ICD-O-3
B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow
+∞
7.3
7
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.3
7
*
C88.9
ICD-10 Finland
Malignant immunoproliferative disease, unspecified
+∞
7.3
7
*
2000B
ICD-9 Finland
Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]
+∞
7.3
7
*
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
+∞
7.3
7
*
9680/3-C77.8
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of lymph nodes of multiple regions
+∞
7.3
7
*
C83
ICD-10 Finland
Non-follicular lymphoma
+∞
7.3
7
*
C96.9
ICD-10 Finland
Malignant neoplasm of lymphoid, haematopoietic and related tissue, unspecified
+∞
7.3
7
*
C82.7
ICD-10 Finland
Other types of follicular lymphoma
+∞
7.3
7
*
C69.00
ICD-10 Finland
Malignant tumor of the conjunctiva without histology
+∞
7.3
7
*
FM1FN
NOMESCO Finland
Heart function isotope examination
+∞
7.3
7
*
C50.31
ICD-10 Finland
Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor
+∞
7.3
7
*
128
Kela drug reimbursment
Cancers of female genital organs
+∞
7.3
7
*
1CX01, ,
NOMESCO Finland
+∞
7.3
7
*
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
+∞
7.3
7
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
7.3
7
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
7.3
7
*
C16.9
ICD-10 Finland
Malignant neoplasm: Stomach, unspecified
+∞
7.3
7
*
EL4AT
NOMESCO Finland
Salivary gland cytology with ultrasound guidance
16.0
7.2
11
7
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
4.0
7.2
20
51
WF099
NOMESCO Finland
Other radiotherapy
30.4
7.2
9
*
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
30.4
7.2
9
*
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.5
7.0
43
178
J01MA02
ATC
ciprofloxacin; systemic
1.6
7.0
219
1579
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.6
7.0
42
172
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
14.0
6.9
11
8
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
16.9
6.8
10
6
WX704
NOMESCO Finland
Intubation
2.5
6.7
44
188
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.1
6.7
27
89
ZXA05
NOMESCO Finland
Left side
1.7
6.6
149
986
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
12.4
6.6
11
9
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
4.2
6.6
17
41
BA3AT
NOMESCO Finland
Cytology of thyroid with ultrasound quidance
6.3
6.5
16
26
L02BA01
ATC
tamoxifen; oral
70.6
6.4
7
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
70.6
6.4
7
*
JAH00
NOMESCO Finland
Laparotomy
3.8
6.4
19
51
D69.3
ICD-10 Finland
Idiopathic thrombocytopenic purpura
8.3
6.4
13
16
R4190
NOMESCO Finland
Nutritional therapy
3.9
6.3
18
47
WE300
NOMESCO Finland
Profylactive therapy of malignancy with biomoidiers
+∞
6.3
6
*
C81.0
ICD-10 Finland
Nodular lymphocyte predominant Hodgkin lymphoma
+∞
6.3
6
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
6.3
6
*
C50.49
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
C83.2
ICD-10 Finland
Mixed small and large cell (diffuse) non-Hodgkin's lymphoma
+∞
6.3
6
*
L02BB03
ATC
bicalutamide; oral
+∞
6.3
6
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
6.3
6
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
+∞
6.3
6
*
C91.9
ICD-10 Finland
Lymphoid leukaemia, unspecified
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
6.3
6
*
L98.9
ICD-10 Finland
Disorder of skin and subcutaneous tissue, unspecified
7.1
6.2
14
20
TGD00
NOMESCO Finland
Needle biopsy of lung
27.0
6.2
8
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
27.0
6.2
8
*
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.3
6.2
23
72
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.8
6.2
100
601
J01CA04
ATC
amoxicillin; systemic
1.7
6.2
439
3794
ELB40
NOMESCO Finland
Partial parotidectomy
6.4
6.2
15
24
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
6.1
64
333

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
248
115
37.11
307.65
2.2
1.2
—
—
—
0
0
267
220
21.76
290.29
1.3
1.4
—
—
—
0
0
153
28
74.05
278.23
1.6
1.1
—
—
—
0
0
289
361
15.06
238.68
1.4
1.4
—
—
—
0
0
299
397
14.58
236.28
1.5
1.4
—
—
—
0
0
320
493
13.35
225.23
1.5
1.6
—
—
—
0
0
125
52
30.42
181.03
1.9
1.5
—
—
—
0
0
230
305
11.89
177.02
4.0
2.2
9.11
10.89
g/l
4.27
221
281
184
251
10.30
135.89
3.0
1.4
2.67
1.12
g/l
3.06
177
228
70
12
66.26
126.45
3.5
1.2
0.37
0.17
e9/l
0.73
70
12
126
9
178.63
123.89
1.5
1.0
—
—
—
0
0
488
2018
10.28
118.43
12.1
5.7
—
—
—
0
0
472
1943
8.92
113.06
10.9
5.4
0.69
0.70
%
0.03
461
1802
478
2007
9.12
111.57
11.3
5.4
2.74
2.99
%
1.30
468
1864
379
1289
6.67
111.49
4.0
2.4
833.87
6966.95
umol/l
3.90
372
1105
189
332
7.98
110.91
2.3
1.5
—
—
—
0
0
477
2012
8.98
110.31
11.9
5.7
9.61
8.69
%
6.63
467
1870
477
2047
8.74
107.04
11.5
5.5
28.90
27.15
%
1.98
467
1911
491
2173
9.54
106.38
10.2
5.2
0.60
0.60
e9/l
0.21
447
1887
491
2183
9.47
105.50
10.2
5.2
0.04
0.04
e9/l
1.49
448
1899
494
2222
9.59
104.40
10.4
5.3
2.02
1.84
e9/l
0.76
460
1972
471
2030
8.24
104.04
10.6
5.3
55.64
57.70
%
2.58
457
1894
494
2263
9.31
100.94
10.7
5.3
0.17
0.20
e9/l
2.16
453
1996
482
2212
8.22
96.40
12.8
3.6
10.65
11.77
umol/l
2.44
475
2068
501
2398
9.37
95.23
21.2
6.1
3.49
4.31
e9/l
16.47
467
2094
184
403
6.24
84.94
4.2
2.2
74.58
68.03
e9/l
1.13
157
319
213
540
5.67
83.55
4.4
2.0
1.90
1.72
%
1.10
201
481
160
324
6.45
79.79
6.4
3.9
0.63
0.76
%
0.37
101
81
174
382
6.09
79.69
2.5
1.6
66.05
67.48
g/l
1.21
163
338
421
1958
5.27
75.13
7.2
3.5
35.21
35.62
g/l
0.81
406
1812
148
300
6.29
73.31
6.4
3.8
0.45
0.61
%
0.37
86
73
51
22
25.34
71.41
4.3
2.3
30.58
51.05
%
2.96
39
12
81
85
10.93
70.89
1.3
1.3
—
—
—
0
0
101
145
8.23
69.19
2.1
1.4
50.20
44.41
mg/l
0.26
87
118
101
146
8.18
68.77
2.0
1.4
26.53
32.39
mg/l
0.81
89
119
145
309
5.93
67.77
6.8
3.9
0.11
0.05
%
0.41
85
64
324
1384
4.07
60.92
2.6
1.6
—
—
—
0
0
205
640
4.42
59.81
5.8
2.6
0.81
0.83
mmol/l
1.33
199
588
82
109
8.61
59.66
2.0
1.4
—
—
—
0
0
434
2300
4.60
59.14
9.4
5.5
1.22
1.21
mmol/l
0.56
368
1973
132
296
5.49
57.75
6.6
4.0
0.04
0.02
%
0.30
69
54
58
54
11.83
54.77
2.9
1.8
33.78
33.22
pg
0.34
58
54
62
65
10.57
53.98
1.5
1.3
—
—
—
0
0
396
2107
3.81
50.22
8.0
5.1
1.22
1.21
mmol/l
1.17
388
1868
57
61
10.26
48.81
1.5
1.3
107.25
112.71
u/ml
—
20
7
93
176
6.11
48.50
2.6
1.4
10.35
10.53
g/l
0.11
87
149
217
810
3.69
47.56
2.2
1.3
1.93
2.80
g/l
5.45
173
465
123
306
4.84
47.07
1.5
1.1
—
—
—
0
0
271
1179
3.45
46.45
7.3
3.9
—
—
—
0
0
51
8
69.72
44.97
2.6
1.4
9.24
2.88
%
—
51
8
51
8
69.72
44.97
2.6
1.4
—
—
—
0
0
308
1483
3.31
44.06
5.9
2.0
2.36
2.35
mmol/l
0.41
288
1225
289
1352
3.28
43.18
6.9
3.2
7.40
7.40
ph
0.03
78
218
519
3524
5.78
42.16
17.9
5.2
80.34
75.54
u/l
2.46
513
3226
358
1955
3.20
40.01
18.0
8.4
0.00
0.00
e9/l
0.12
313
1603
38
30
13.49
39.53
6.7
3.8
—
—
—
0
0
48
55
9.43
38.93
3.0
2.1
—
—
—
0
0
41
38
11.54
38.61
1.0
1.2
—
—
—
0
0
73
148
5.50
35.03
2.8
1.3
38.53
37.83
g/l
0.45
68
121
345
1967
2.88
33.47
3.8
2.2
—
—
—
0
0
501
3534
4.21
33.23
7.7
4.2
17.48
12.37
mm/h
6.76
485
3218
218
978
2.98
33.23
15.3
4.6
—
—
—
0
0
91
240
4.32
31.74
2.3
1.4
2.98
2.67
ug/l
0.21
65
183
222
1039
2.85
30.88
5.1
3.4
85.84
86.91
%
0.27
211
1005
35
7
53.06
29.70
1.5
1.0
—
—
—
0
0
247
1269
2.66
28.06
4.0
2.0
—
—
—
0
0
40
57
7.47
27.04
2.0
2.5
—
—
—
0
0
360
2250
2.60
26.71
13.2
16.5
1.14
1.34
inr
6.24
114
642
74
196
4.18
25.49
4.0
1.6
1.45
1.52
g/l
0.24
63
171
41
67
6.51
24.42
1.2
1.2
258.42
272.84
u/ml
0.10
26
38
143
591
2.89
24.36
2.4
2.5
22.92
23.88
%
0.21
124
501
200
981
2.59
24.33
3.5
1.9
—
—
—
0
0
149
633
2.83
24.08
2.4
2.4
2.23
2.31
g/l
0.82
139
585
31
38
8.57
23.71
1.3
1.2
—
—
—
0
0
151
677
2.67
21.75
2.7
1.8
29.89
29.49
s
0.32
144
653
38
67
6.00
20.97
1.3
1.3
131.38
261.50
miu/ml
—
9
25
152
696
2.61
20.89
2.6
2.3
12.74
13.44
umol/l
0.38
145
642
393
2769
2.32
19.37
5.6
4.4
6.59
6.81
mmol/l
1.42
384
2573
232
1345
2.21
18.28
3.7
3.2
40.03
89.54
e6/l
0.49
179
1040
109
451
2.75
18.12
3.7
2.1
5.74
7.24
umol/l
1.06
100
388
42
94
4.74
17.81
1.3
1.2
—
—
—
0
0
258
1581
2.14
17.46
4.3
3.6
51.34
90.21
e6/l
1.14
183
1124
215
1239
2.17
16.93
3.6
3.0
0.25
0.40
e6/l
1.51
163
942
209
1198
2.17
16.62
3.6
3.0
—
—
—
0
0
33
64
5.41
16.46
1.1
1.0
—
—
—
0
0
207
1186
2.16
16.45
2.4
2.2
3.07
3.00
mg/l
0.17
183
994
89
354
2.79
15.85
1.9
1.8
0.19
0.21
g/l
0.96
78
317
132
643
2.37
15.41
1.9
1.9
—
—
—
0
0
29
57
5.30
14.25
1.1
1.0
—
—
—
0
0
38
94
4.26
14.22
1.8
2.0
43.19
68.39
u/ml
0.18
32
71
417
3211
2.08
13.72
5.1
4.2
—
—
—
0
0
24
42
5.92
13.30
1.1
1.3
—
—
—
0
0
33
77
4.49
13.29
4.9
3.4
55.76
59.26
%
0.59
33
77
127
647
2.24
13.17
1.7
1.2
—
—
—
0
0
283
1928
1.92
13.10
2.6
2.3
81.00
78.52
nmol/l
0.65
266
1667
276
1871
1.91
12.92
3.4
2.6
272.46
130.27
ug/l
3.88
258
1692
25
47
5.52
12.87
1.5
1.3
6.97
6.36
g/l
0.17
17
32
25
47
5.52
12.87
1.5
1.3
0.30
0.33
g/l
0.13
17
32
25
47
5.52
12.87
1.6
1.3
—
—
—
0
0
25
47
5.52
12.87
1.5
1.3
1.87
2.66
g/l
1.09
18
32
136
723
2.15
12.63
2.9
2.9
2.02
2.02
e6/l
0.00
71
399
25
27
9.63
12.59
1.1
1.1
—
—
—
0
0
25
27
9.63
12.59
2.2
2.2
—
—
—
0
0
394
3019
1.97
12.53
5.5
4.4
2356.14
3620.27
e6/l
—
7
48
182
1085
1.99
12.37
1.6
1.3
—
—
—
0
0
158
896
2.05
12.34
3.2
2.8
513.59
533.57
mosm/kgh2o
0.61
143
763
163
936
2.03
12.30
3.1
2.4
5.05
5.25
e6/l
0.10
151
843
166
963
2.02
12.15
3.3
4.1
248.30
488.55
ng/l
0.63
135
790
30
71
4.40
11.87
1.7
1.6
0.39
1.05
g/l
1.99
21
54
31
76
4.25
11.73
4.5
3.1
3.12
4.56
e9/l
4.37
31
76
82
367
2.44
11.37
6.1
7.2
—
—
—
0
0
98
480
2.26
11.05
5.6
3.3
—
—
—
0
0
139
785
2.02
10.82
2.8
2.7
0.89
1.07
e6/l
0.31
72
459
10
0
+∞
10.44
4.9
0.0
0.40
—
umol/l
—
10
0
80
375
2.32
9.97
2.1
2.2
29.26
45.41
u/l
0.72
65
308
524
4602
2.54
9.79
33.3
12.9
21.47
23.66
mg/l
0.75
490
3561
41
140
3.08
9.55
2.0
1.9
21.22
21.43
s
0.09
36
125
63
274
2.46
9.26
3.1
2.9
10.38
4.76
e9/l
0.54
52
210
204
1380
1.74
8.72
6.2
2.6
28.33
34.42
u/l
2.13
195
1306
43
162
2.79
8.42
2.2
1.8
—
—
—
0
0
14
11
13.01
8.41
1.2
1.0
—
—
—
0
0
55
236
2.47
8.32
4.7
8.2
25.37
25.27
mmol/l
0.06
55
236
209
1442
1.71
8.22
3.8
3.2
—
—
—
0
0
153
972
1.78
8.03
1.8
1.6
1.59
1.22
mg/l
0.93
120
736
53
236
2.37
7.40
5.3
9.8
—
—
—
0
0
39
155
2.63
6.92
2.4
2.7
0.91
0.28
g/l
0.62
20
47
16
24
6.82
6.85
2.5
2.8
3260.44
1330.29
u/ml
0.81
16
24
39
156
2.61
6.83
2.5
1.5
0.17
0.23
g/l
3.45
32
151
17
28
6.22
6.81
2.2
1.1
—
—
—
0
0
13
14
9.47
6.81
1.2
1.0
—
—
—
0
0
87
489
1.92
6.68
5.3
6.9
96.92
94.96
%
3.67
82
474
104
620
1.83
6.64
1.3
1.3
935.00
582.67
titre
0.80
32
150
48
217
2.32
6.49
1.4
1.2
—
—
—
0
0
94
549
1.85
6.40
5.3
6.6
5.20
5.14
kpa
0.21
89
530
94
549
1.85
6.40
5.3
6.6
13.37
11.32
kpa
3.11
89
530
17
31
5.62
6.34
1.4
1.1
—
—
—
0
0
68
359
2.01
6.24
4.5
3.7
—
—
—
0
0
202
1462
1.59
6.21
2.8
2.2
56.76
60.38
u/l
0.42
187
1333
10
8
12.69
6.10
3.2
1.0
—
—
—
0
0
22
68
3.32
6.06
1.0
1.1
—
—
—
0
0
35
142
2.56
5.98
1.4
1.2
2.17
3.07
u/ml
0.47
11
18
178
1260
1.60
5.97
1.7
1.5
20.56
20.81
nmol/l
0.07
159
1056
93
553
1.81
5.97
5.3
6.5
1.21
1.42
mmol/l
0.26
78
439
14
22
6.49
5.89
1.2
1.1
—
—
—
0
0
399
3393
1.57
5.79
4.3
4.1
—
—
—
0
0
35
145
2.51
5.74
1.4
1.2
1.84
7.65
u/ml
0.90
14
23
18
51
3.61
5.64
2.2
1.1
29.54
28.24
g/l
0.16
18
44
20
61
3.36
5.63
1.4
1.3
116.00
62.66
pmol/l
1.44
20
61
38
167
2.37
5.50
1.5
1.2
—
—
—
0
0
21
68
3.17
5.39
1.0
1.1
—
—
—
0
0
269
2132
1.49
5.22
2.3
2.0
93.93
94.92
pmol/l
0.11
160
1059
149
1040
1.58
5.21
1.9
1.8
1165.41
1192.07
nmol/l
0.13
118
786
283
2278
1.48
5.01
3.7
3.8
0.00
0.00
estimate
0.50
78
418
16
37
4.42
4.97
2.3
1.1
—
—
—
0
0
207
1569
1.50
4.93
2.9
3.0
1644.73
1405.55
ng/l
0.36
181
1332
18
56
3.29
4.93
1.4
1.5
—
—
—
0
0
283
2295
1.46
4.73
3.9
3.8
0.00
0.01
estimate
0.50
75
381
14
30
4.76
4.71
1.6
1.7
—
—
—
0
0
344
2900
1.46
4.67
3.6
2.9
49.31
46.57
u/l
0.30
319
2654
12
22
5.55
4.62
1.3
2.0
1.87
3.13
nmol/l
0.86
12
22
14
31
4.60
4.58
1.1
1.4
—
—
—
0
0
279
2270
1.44
4.51
5.1
5.1
0.00
0.00
estimate
-0.00
73
381
74
448
1.75
4.46
4.4
3.3
1.77
2.27
mmol/l
0.44
65
379
8
9
8.99
4.29
1.0
1.1
—
—
—
0
0
23
90
2.62
4.27
1.6
1.1
—
—
—
0
0
82
518
1.68
4.24
1.8
1.7
—
—
—
0
0
15
46
3.32
4.21
1.5
1.1
1167.38
2490.83
e6/l
—
8
30
14
41
3.47
4.21
1.6
1.1
13766.67
223092.50
e6/l
—
6
22
11
21
5.32
4.16
1.5
1.4
21.49
13.42
ug/l
0.67
11
21
54
311
1.81
3.86
5.6
3.5
7.43
7.41
ph
—
8
39
22
89
2.53
3.84
2.0
2.7
—
—
—
0
0
84
555
1.60
3.64
1.8
1.5
—
—
—
0
0
32
157
2.10
3.63
1.6
1.5
—
—
—
0
0
24
105
2.34
3.57
3.4
2.5
1.74
1.68
mg/l
0.14
24
94
38
201
1.95
3.53
1.6
1.5
—
—
—
0
0
42
232
1.87
3.44
5.0
3.5
—
—
—
0
0
63
397
1.66
3.30
1.8
1.5
—
—
—
0
0
69
448
1.61
3.22
2.1
3.3
302.09
214.78
ng/l
0.53
64
414
7
11
6.43
3.19
2.4
1.9
—
—
—
0
0
40
224
1.84
3.16
1.2
1.6
—
12.04
—
0
5
11
30
3.72
3.10
1.1
1.2
—
—
—
0
0
23
106
2.22
3.07
3.8
2.1
119.17
133.47
g/l
1.69
12
77
12
36
3.38
3.03
1.4
1.1
—
—
—
0
0
237
1969
1.35
3.01
3.8
3.8
23.56
42.79
ng/l
2.93
179
1433
52
322
1.68
2.93
1.3
1.2
—
—
—
0
0
6
9
6.72
2.87
1.5
1.2
—
—
—
0
0
6
9
6.72
2.87
1.7
1.4
—
—
—
0
0
423
4565
0.72
2.86
5.8
6.4
39.79
40.58
mmol/mol
1.00
383
4201
8
18
4.49
2.80
2.1
1.0
—
—
—
0
0
19
84
2.30
2.80
4.7
2.7
—
—
—
0
0
69
464
1.55
2.80
1.4
1.3
—
—
—
0
0
7
14
5.05
2.73
1.1
1.2
—
—
—
0
0
53
339
1.62
2.65
4.0
4.7
—
—
—
0
0
122
929
1.40
2.64
1.3
1.2
3.67
1.63
u/ml
0.49
28
253
33
186
1.82
2.59
2.0
2.2
137.97
581.09
ug/l
1.14
33
172
5
7
7.19
2.55
1.6
1.4
—
—
—
0
0
185
1517
1.32
2.48
4.3
4.0
—
—
—
0
0
8
22
3.67
2.37
1.0
1.0
—
—
—
0
0
6
13
4.65
2.27
1.0
1.8
—
—
—
0
0
7
18
3.92
2.26
1.0
1.1
—
—
—
0
0
7
18
3.92
2.26
1.0
1.1
—
—
—
0
0
7
18
3.92
2.26
1.0
1.1
—
—
—
0
0
219
1857
1.29
2.25
3.3
3.5
5.27
5.88
ph
0.79
13
104
23
121
1.94
2.24
1.5
1.4
282.56
311.94
ug/g
0.27
18
74
32
188
1.74
2.22
1.8
1.9
—
—
—
0
0
5
9
5.59
2.21
1.6
1.7
—
—
—
0
0
24
129
1.90
2.20
2.7
3.2
—
—
—
0
0
105
804
1.37
2.19
1.3
1.3
62.92
39.10
iu/ml
0.77
37
252
389
3555
1.29
2.16
3.8
3.8
14.75
15.00
pmol/l
1.06
357
3178
8
25
3.23
2.10
1.3
1.3
—
—
—
0
0
32
509
0.61
2.04
1.4
1.6
—
—
—
0
0
9
32
2.84
2.00
1.0
1.1
—
—
—
0
0
44
291
1.55
1.96
1.3
1.3
—
—
—
0
0
10
39
2.59
1.95
1.1
1.1
—
—
—
0
0
54
376
1.48
1.91
5.1
3.7
94.37
86.57
ng/l
0.26
49
332
43
287
1.54
1.86
1.3
1.3
—
38.81
—
0
17
509
4864
1.40
1.83
25.9
12.5
—
—
—
0
0
17
87
1.98
1.81
4.9
4.0
—
—
—
0
0
12
54
2.25
1.75
1.1
1.3
—
—
—
0
0
130
1563
0.78
1.68
2.7
3.2
—
—
—
0
0
6
19
3.18
1.66
1.2
1.1
—
—
—
0
0
40
270
1.52
1.66
2.5
2.5
—
—
—
0
0
18
99
1.84
1.59
1.2
1.2
—
—
—
0
0
6
20
3.02
1.58
1.2
1.1
—
—
—
0
0
97
774
1.30
1.55
1.2
1.3
5.94
14.36
u/ml
1.62
34
292
17
93
1.85
1.53
4.8
2.8
14.54
16.24
%
—
10
47
17
293
0.57
1.52
1.4
1.4
—
—
—
0
0
14
72
1.97
1.50
2.0
1.8
333.93
267.83
mu/l
0.38
14
66
9
38
2.39
1.46
1.2
1.1
—
—
—
0
0
11
52
2.14
1.45
1.2
1.1
—
—
—
0
0
16
89
1.82
1.38
1.1
1.7
—
—
—
0
0
147
1254
1.23
1.36
4.3
4.0
0.00
0.01
estimate
0.50
74
380
6
24
2.52
1.30
1.0
1.3
—
—
—
0
0
16
91
1.78
1.30
2.7
4.9
5.07
5.18
kpa
0.25
16
91
132
1119
1.23
1.29
3.6
3.7
—
—
—
0
0
16
92
1.76
1.26
2.8
4.9
8.61
8.24
kpa
0.34
16
92
139
1189
1.22
1.25
3.8
3.4
—
—
—
0
0
17
100
1.72
1.24
3.6
2.8
—
—
—
0
0
8
36
2.24
1.24
1.8
2.3
—
—
—
0
0
9
45
2.02
1.23
1.2
1.1
—
—
—
0
0
9
45
2.02
1.23
1.2
1.1
—
—
—
0
0
5
19
2.65
1.22
1.4
1.1
5.30
7.10
mmol/l
—
5
19
43
316
1.39
1.21
2.8
2.8
—
—
—
0
0
155
1770
0.83
1.19
4.1
3.8
12.70
8.39
mg/mmol
0.31
94
1115
533
5187
1.37
1.19
45.9
18.9
38.45
40.31
%
9.19
505
4772
533
5189
1.36
1.16
46.0
18.9
6.67
6.72
e9/l
0.12
526
5015
5
20
2.51
1.15
1.6
1.4
—
—
—
0
0
5
20
2.51
1.15
1.2
1.2
—
—
—
0
0
533
5190
1.36
1.15
46.0
18.9
4.28
4.50
e12/l
14.61
526
5012
458
4758
0.82
1.14
4.1
4.8
1.37
1.46
mmol/l
4.47
407
4335
463
4804
0.82
1.13
4.2
4.9
4.44
4.57
mmol/l
1.82
413
4405
473
4897
0.81
1.13
4.7
5.5
2.59
2.68
mmol/l
1.19
421
4470
12
66
1.84
1.09
1.4
1.2
—
—
—
0
0
178
1579
1.18
1.08
2.0
2.2
202.98
261.22
u/l
0.37
166
1478
532
5187
1.34
1.06
46.3
18.8
220.22
245.09
e9/l
12.50
525
5027
8
147
0.54
1.05
1.4
1.6
—
—
—
0
0
9
46
1.97
1.04
1.7
1.5
274.44
271.27
mosm/kgh2o
—
9
30
20
131
1.55
1.01
1.5
1.2
—
—
—
0
0
13
76
1.73
0.99
2.5
2.2
—
—
—
0
0
7
37
1.90
0.94
1.0
1.0
—
—
—
0
0
7
37
1.90
0.94
1.9
1.1
—
—
—
0
0
8
47
1.71
0.81
1.3
1.3
—
—
—
0
0
5
25
2.01
0.73
1.6
1.4
9.80
10.80
mmol/l
—
5
25
153
1684
0.88
0.71
3.5
3.3
2793.43
222.36
mg/l
1.89
100
1070
9
58
1.56
0.70
1.1
1.2
—
—
—
0
0
5
27
1.86
0.68
1.2
2.2
—
—
—
0
0
7
42
1.67
0.68
4.0
2.0
9.10
10.92
%
—
7
42
116
1034
1.15
0.67
3.0
2.7
0.85
0.73
ug/l
0.56
81
677
5
28
1.79
0.66
1.2
1.6
73.40
77.04
umol/l
—
5
28
449
4354
1.14
0.65
4.9
4.7
1.94
2.26
mu/l
0.59
415
3915
32
252
1.29
0.64
1.2
1.2
136.33
109.78
iu/ml
—
10
104
5
29
1.73
0.64
1.4
1.5
—
—
—
0
0
127
1145
1.14
0.63
1.6
1.7
495.82
26167647.38
pmol/l
1.25
103
921
5
30
1.67
0.61
1.4
1.3
0.94
1.00
g/l
—
5
30
57
483
1.20
0.61
2.1
2.2
200.98
160.74
ug/g
0.41
51
378
0
20
0.00
0.60
0.0
10.0
—
884.00
—
0
20
0
20
0.00
0.60
0.0
12.5
—
1639.80
—
0
20
14
197
0.70
0.59
11.6
10.2
—
—
—
0
0
158
1714
0.89
0.58
3.3
3.1
7.20
7.52
mmol/l
0.47
129
1436
450
4616
0.89
0.56
3.7
4.3
1.30
1.30
mmol/l
0.08
397
4173
8
55
1.46
0.56
1.4
1.3
—
—
—
0
0
35
288
1.23
0.51
2.1
2.3
13.64
15.02
nmol/l
0.37
29
257
11
75
1.48
0.51
2.5
2.3
—
—
—
0
0
17
127
1.35
0.50
2.4
2.5
—
—
—
0
0
11
76
1.46
0.48
2.5
2.3
4.25
4.08
mmol/l
0.66
11
76
11
76
1.46
0.48
2.5
2.3
105.91
105.26
mmol/l
0.16
11
76
32
263
1.23
0.48
3.4
2.9
24.63
25.28
mmol/l
0.57
32
256
16
209
0.76
0.46
1.6
1.5
—
—
—
0
0
5
33
1.52
0.41
1.0
1.1
—
5.03
—
0
8
0
16
0.00
0.41
0.0
5.1
—
—
—
0
0
0
17
0.00
0.40
0.0
10.6
—
0.64
—
0
17
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
486
4775
1.11
0.40
5.0
4.9
5.95
6.05
mmol/l
1.16
439
4309
32
270
1.20
0.39
2.8
3.5
—
—
—
0
0
99
1076
0.90
0.39
4.2
4.1
1.02
1.02
kg/l
0.06
20
152
38
440
0.85
0.38
4.5
3.2
—
—
—
0
0
9
66
1.37
0.38
1.1
1.2
—
—
—
0
0
125
1342
0.91
0.38
1.7
1.7
1.36
1.37
mmol/l
0.03
106
1104
9
69
1.31
0.37
1.1
1.2
—
—
—
0
0
9
69
1.31
0.37
1.1
1.2
—
—
—
0
0
10
72
1.40
0.37
1.4
1.4
51.82
70.00
%
—
5
45
9
71
1.27
0.36
1.1
1.2
—
—
—
0
0
9
71
1.27
0.36
1.1
1.2
—
—
—
0
0
11
82
1.35
0.34
1.4
1.5
—
—
—
0
0
13
100
1.31
0.34
1.2
1.6
—
—
—
0
0
44
388
1.15
0.33
1.4
1.5
—
—
—
0
0
6
88
0.68
0.33
1.3
1.1
—
—
—
0
0
7
54
1.30
0.30
1.0
1.0
1.74
1.51
g/l
—
7
46
14
114
1.23
0.25
4.0
3.6
25.00
26.82
mg/l
—
9
76
29
257
1.14
0.22
1.2
1.3
—
—
—
0
0
190
1833
1.05
0.22
4.7
3.9
2.61
1.92
ug/l
0.92
170
1624
16
135
1.19
0.21
3.8
4.5
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
11
0.00
0.21
0.0
5.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
19
219
0.86
0.21
4.1
4.4
—
—
—
0
0
17
146
1.17
0.19
1.1
1.1
—
—
—
0
0
7
63
1.11
0.17
1.1
1.3
—
—
—
0
0
15
165
0.91
0.09
1.2
1.1
—
—
—
0
0
6
56
1.07
0.08
1.2
2.4
—
—
—
0
0
7
67
1.05
0.08
1.1
1.3
—
—
—
0
0
6
70
0.86
0.07
2.8
2.7
—
—
—
0
0
9
86
1.05
0.07
1.7
1.9
217.78
226.35
pmol/l
—
9
78
10
106
0.94
0.01
1.8
1.9
44.50
42.63
nmol/l
—
10
101
11
116
0.95
0.00
1.1
1.1
—
—
—
0
0
10
95
1.05
0.00
2.0
1.7
—
—
—
0
0
50
505
0.99
0.00
1.9
2.4
4.18
7.94
ug/l
2.30
43
436
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
0.00
0.0
6.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
7
73
0.96
-0.00
1.1
1.3
0.59
0.63
nmol/l
—
7
65
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
-0.00
1.1
1.3
—
0.61
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_MARGINAL_ZONE_LYMPHOMA_WIDE – Marginal zone B-cell lymphoma, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).